A patient with minimal myeloma treatment who survived for 20 years

• Alenka Djarmila Behsen,
• Esten Nymoen Vandsemb,
• Tobias Schmidt Slørdahl,
• Henrik Hjorth-Hansen,
• Petter Quist-Paulsen,
• Kristine Misund,
• Anne-Marit Sponaas,
• Anders Waage

Affiliations

Alenka Djarmila Behsen

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim

Esten Nymoen Vandsemb

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim

Tobias Schmidt Slørdahl

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim

Henrik Hjorth-Hansen

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim

Petter Quist-Paulsen

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Hematology, St. Olavs Hospital, Trondheim

Kristine Misund

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Department of Medical Genetics, St. Olavs Hospital, Trondheim

Anne-Marit Sponaas

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim

Anders Waage

Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, Trondheim, Norway; Biobank1, St. Olavs Hospital, Trondheim